Developing Mucosal Vaccines for Severe Acute Respiratory Syndrome Coronavirus 2: What Will It Take?
Clin Infect Dis
.
2023 Apr 17;76(8):1400-1402.
doi: 10.1093/cid/ciac935.
Authors
Kathryn M Edwards
1
,
Kathleen M Neuzil
2
Affiliations
1
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
2
Department of Medicine and Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
PMID:
36482757
DOI:
10.1093/cid/ciac935
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination
Vaccines*
Substances
Vaccines